Holen Sie sich die Stockscreener-App
22.39
0.44%
-0.10
Handel nachbörslich:
22.39
Schlusskurs vom Vortag:
$22.49
Offen:
$22.46
24-Stunden-Volumen:
150.77K
Relative Volume:
0.58
Marktkapitalisierung:
$685.34M
Einnahmen:
$290.71M
Nettoeinkommen (Verlust:
$-163.43M
KGV:
-4.0858
EPS:
-5.48
Netto-Cashflow:
$11.70M
1W Leistung:
-1.06%
1M Leistung:
+2.33%
6M Leistung:
+18.15%
1J Leistung:
+10.02%
1-Tages-Spanne:
$22.26
$22.68
1-Wochen-Bereich:
$22.09
$23.09
52-Wochen-Spanne:
$14.76
$23.57
Fulgent Genetics Inc Stock (FLGT) Company Profile
Firmenname
Fulgent Genetics Inc
Sektor
Branche
Telefon
626-350-0537
Adresse
4399 SANTA ANITA AVE, EL MONTE
Vergleichen Sie FLGT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
FLGT
Fulgent Genetics Inc
|
22.39 | 689.01M | 290.71M | -163.43M | 11.70M | -5.48 |
|
TMO
Thermo Fisher Scientific Inc
|
525.83 | 198.09B | 43.21B | 6.58B | 6.17B | 17.28 |
|
DHR
Danaher Corp
|
206.15 | 146.89B | 24.01B | 3.41B | 4.86B | 4.7082 |
|
IDXX
Idexx Laboratories Inc
|
636.91 | 50.67B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
138.04 | 39.19B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
204.76 | 34.64B | 15.70B | 1.24B | 2.01B | 6.9036 |
Fulgent Genetics Inc Stock (FLGT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-05 | Hochstufung | UBS | Neutral → Buy |
| 2023-12-07 | Eingeleitet | UBS | Neutral |
| 2022-12-08 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-11-18 | Eingeleitet | Raymond James | Outperform |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2022-02-04 | Fortgesetzt | Piper Sandler | Overweight |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Underperform |
| 2021-01-08 | Herabstufung | Credit Suisse | Neutral → Underperform |
| 2020-11-24 | Herabstufung | BTIG Research | Buy → Neutral |
| 2020-08-20 | Eingeleitet | Oppenheimer | Outperform |
| 2020-05-29 | Eingeleitet | BTIG Research | Buy |
| 2019-11-05 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2018-03-01 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2017-11-07 | Herabstufung | Raymond James | Outperform → Mkt Perform |
Alle ansehen
Fulgent Genetics Inc Aktie (FLGT) Neueste Nachrichten
Can Fulgent Genetics Inc. stock resist sector downturnsEntry Point & Real-Time Buy Signal Alerts - newser.com
Is Fulgent Genetics Inc. stock cheap at current valuation2025 Stock Rankings & AI Forecasted Stock Moves - newser.com
Why Fulgent Genetics Inc. stock is trending among retail traders2025 Market Sentiment & Breakout Confirmation Trade Signals - newser.com
Multi factor analysis applied to Fulgent Genetics Inc.Rate Hike & Breakout Confirmation Alerts - newser.com
What dividend safety score for Fulgent Genetics Inc. stockEarnings Recap Report & Daily Profit Focused Screening - newser.com
How institutional ownership impacts Fulgent Genetics Inc. stockQuarterly Profit Report & Free Real-Time Volume Trigger Notifications - newser.com
Is Fulgent Genetics Inc. stock a contrarian buy2025 Breakouts & Breakdowns & Free Expert Verified Stock Movement Alerts - newser.com
Sentiment analysis tools applied to Fulgent Genetics Inc.Quarterly Profit Report & Daily Profit Focused Screening - newser.com
How to integrate Fulgent Genetics Inc. into portfolio analysis toolsWeekly Profit Summary & Fast Exit and Entry Strategy Plans - newser.com
Will Fulgent Genetics Inc. rebound enough to break evenJuly 2025 Highlights & Consistent Growth Equity Picks - newser.com
Institutional scanner results for Fulgent Genetics Inc.Quarterly Market Summary & Risk Controlled Daily Trade Plans - newser.com
Fulgent Genetics, Inc. (FLGT) Stock Analysis: Exploring a Promising 11.65% Upside Potential - DirectorsTalk Interviews
Is Fulgent Genetics Inc. stock a safe haven assetSell Signal & Safe Entry Point Identification - newser.com
Market reaction to Fulgent Genetics Inc.’s recent newsJuly 2025 EndofMonth & Real-Time Stock Movement Alerts - newser.com
Fulgent Genetics (NASDAQ:FLGT) Earns “Sell (D-)” Rating from Weiss Ratings - Defense World
Signaturefd LLC Has $38,000 Holdings in Fulgent Genetics, Inc. $FLGT - Defense World
What to do if you’re stuck in Fulgent Genetics Inc.July 2025 Catalysts & Fast Gaining Stock Strategy Reports - newser.com
Is Fulgent Genetics Inc. trending in predictive chart models2025 Growth vs Value & Weekly Watchlist for Hot Stocks - newser.com
How hedge fund analytics apply to Fulgent Genetics Inc. stockJuly 2025 Pullbacks & Short-Term Swing Trade Alerts - newser.com
Quantitative breakdown of Fulgent Genetics Inc. recent moveQuarterly Earnings Summary & Long-Term Capital Growth Strategies - newser.com
Can machine learning forecast Fulgent Genetics Inc. recovery2025 EndofYear Setup & Free High Return Stock Watch Alerts - newser.com
Fulgent Genetics Hits New 52-Week High at $23.57 - Markets Mojo
Why Fulgent Genetics Inc. (7F0) stock is favored by hedge fundsQuarterly Trade Report & Daily Stock Trend Reports - newser.com
What analysts say about Fulgent Genetics Inc 7F0 stockStock Price Forecasts & Follow Top Performers in the Community - earlytimes.in
Fulgent Genetics (NASDAQ:FLGT) Sets New 12-Month HighHere's Why - MarketBeat
Is Fulgent Genetics Inc. stock attractive for retirement portfoliosJuly 2025 News Drivers & Reliable Volume Spike Alerts - newser.com
Critical Contrast: CVR Medical (OTCMKTS:CRRVF) & Fulgent Genetics (NASDAQ:FLGT) - Defense World
What drives Fulgent Genetics Inc stock priceIndustrial Stocks Review & Small Capital Investment Tips - Early Times
Finanzdaten der Fulgent Genetics Inc-Aktie (FLGT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.95%
1.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):